Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Heron Therapeutics, Inc. /DE/(HRTX US)

$0.29-0.013.15%(Market Open · 20:46:47 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Heron Therapeutics, Inc. /DE/(HRTX US)

$0.29-0.013.15%(Market Open · 20:46:47 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
HRTX US​
Ask AI
HRTX US​
Ask AI

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY198912/31/1989
FY199012/31/1990
FY199112/31/1991
FY199212/31/1992
FY199312/31/1993
FY199412/31/1994
FY199512/31/1995
FY199612/31/1996
FY199712/31/1997
FY199812/31/1998
FY199912/31/1999
FY200012/31/2000
FY200112/31/2001
FY200212/31/2002
FY200312/31/2003
FY200412/31/2004
FY200512/31/2005
FY200612/31/2006
FY200712/31/2007
FY200812/31/2008
FY200912/31/2009
FY201012/31/2010
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-110.6-13.6-20.2-30.9
Depreciation & Amortization2.92.52.32.3
Stock Based Compensation32.913.010.310.8
Change in Working Capital16.8-27.6-31.9-14.4
Other Non-Cash Items-0.83.211.812.0
Net Cash from Operating Activities-58.8-22.5-27.6-20.3
-Investments in Property, Plant & Equipment-1.5-1.7-0.3-0.6
-Acquisitions Net0.00.0-0.1
-Purchases of Investments-87.7-103.1-50.8-41.0
Sales/Maturities of Investments107.2123.567.054.4
Other Investing Activities--0.1-0.0
Net Cash from Investing Activities18.018.716.012.8
Net Debt Issuance24.4-145.19.4
Net Stock Issuance29.80.919.319.2
-Net Dividends Paid----
Other Financing Activities---150.0-14.3
Net Cash from Financing Activities54.10.914.414.3
Effect of Forex Changes----
Net Change in Cash13.3-2.92.86.8
Cash at End of Period28.725.828.6114.3
Operating Cash Flow-58.8-22.5-27.6-20.3
-Capital Expenditure-1.5-1.7-0.3-0.6
Free Cash Flow-60.3-24.2-27.9-20.9

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY198912/31/1989
FY199012/31/1990
FY199112/31/1991
FY199212/31/1992
FY199312/31/1993
FY199412/31/1994
FY199512/31/1995
FY199612/31/1996
FY199712/31/1997
FY199812/31/1998
FY199912/31/1999
FY200012/31/2000
FY200112/31/2001
FY200212/31/2002
FY200312/31/2003
FY200412/31/2004
FY200512/31/2005
FY200612/31/2006
FY200712/31/2007
FY200812/31/2008
FY200912/31/2009
FY201012/31/2010
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-110.6-13.6-20.2-30.9
Depreciation & Amortization2.92.52.32.3
Stock Based Compensation32.913.010.310.8
Change in Working Capital16.8-27.6-31.9-14.4
Other Non-Cash Items-0.83.211.812.0
Net Cash from Operating Activities-58.8-22.5-27.6-20.3
-Investments in Property, Plant & Equipment-1.5-1.7-0.3-0.6
-Acquisitions Net0.00.0-0.1
-Purchases of Investments-87.7-103.1-50.8-41.0
Sales/Maturities of Investments107.2123.567.054.4
Other Investing Activities--0.1-0.0
Net Cash from Investing Activities18.018.716.012.8
Net Debt Issuance24.4-145.19.4
Net Stock Issuance29.80.919.319.2
-Net Dividends Paid----
Other Financing Activities---150.0-14.3
Net Cash from Financing Activities54.10.914.414.3
Effect of Forex Changes----
Net Change in Cash13.3-2.92.86.8
Cash at End of Period28.725.828.6114.3
Operating Cash Flow-58.8-22.5-27.6-20.3
-Capital Expenditure-1.5-1.7-0.3-0.6
Free Cash Flow-60.3-24.2-27.9-20.9